Scotts Miracle-Gro Co (SMG) stock
SMGNYSEAgricultural ChemicalsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3013% above fair value
$62.55−1.21 (-1.90%)
Close on Nov 17, 2026Market cap $3.64BP/E 51.7Yield 4.22%
Scotts Miracle-Gro EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Scotts Miracle-Gro's EPS for the twelve months ending Jun 27, 2026 was $1.21. For fiscal 2025 it was $2.47. Over ten years it grew -0.4% a year on average. The highest annual figure on record is $8.96 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.47 | – |
| FY2024 | Sep 30, 2024 | -$0.61 | – |
| FY2023 | Sep 30, 2023 | -$6.79 | – |
| FY2022 | Sep 30, 2022 | -$7.88 | -187.9% |
| FY2021 | Sep 30, 2021 | $8.96 | +31.6% |
| FY2020 | Sep 30, 2020 | $6.81 | -16.7% |
| FY2019 | Sep 30, 2019 | $8.18 | +630.4% |
| FY2018 | Sep 30, 2018 | $1.12 | -69.1% |
| FY2017 | Sep 30, 2017 | $3.63 | -28.7% |
| FY2016 | Sep 30, 2016 | $5.09 | +98.1% |
| FY2015 | Sep 30, 2015 | $2.57 | -3.0% |
| FY2014 | Sep 30, 2014 | $2.65 | +3.1% |
| FY2013 | Sep 30, 2013 | $2.57 | +50.3% |
| FY2012 | Sep 30, 2012 | $1.71 | -32.7% |
| FY2011 | Sep 30, 2011 | $2.54 | -15.9% |
| FY2010 | Sep 30, 2010 | $3.02 | +30.2% |
| FY2009 | Sep 30, 2009 | $2.32 | – |
| FY2008 | Sep 30, 2008 | -$0.17 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 27, 2026 | $1.90 | -25.2% |
| Q2 FY2026CQ1 2026 | Mar 28, 2026 | $4.04 | +8.6% |
| Q1 FY2026CQ4 2025 | Dec 27, 2025 | -$2.16 | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$2.57 | -212.7% |
| Q3 FY2025CQ2 2025 | Jun 28, 2025 | $2.54 | -7.3% |
| Q2 FY2025CQ1 2025 | Mar 29, 2025 | $3.72 | – |
| Q1 FY2025CQ4 2024 | Dec 28, 2024 | -$1.21 | -257.1% |
| Q3 FY2024CQ2 2024 | Jun 29, 2024 | $2.28 | +17.5% |
| Q2 FY2024CQ1 2024 | Mar 30, 2024 | $2.74 | – |
| Q1 FY2024CQ4 2023 | Dec 30, 2023 | -$1.42 | – |
| Q3 FY2023CQ2 2023 | Jul 1, 2023 | $0.77 | – |
| Q2 FY2023CQ1 2023 | Apr 1, 2023 | $1.94 | -60.7% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$1.17 | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$3.99 | – |
| Q3 FY2022CQ2 2022 | Jul 2, 2022 | -$8.01 | -303.3% |
| Q2 FY2022CQ1 2022 | Apr 2, 2022 | $4.94 | -9.0% |
| Q1 FY2022CQ4 2021 | Jan 1, 2022 | -$0.90 | -309.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$0.83 | -1285.7% |
| Q3 FY2021CQ2 2021 | Jul 3, 2021 | $3.94 | +11.0% |
| Q2 FY2021CQ1 2021 | Apr 3, 2021 | $5.43 | +21.5% |
| Q1 FY2021CQ4 2020 | Jan 2, 2021 | $0.43 | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $0.07 | – |
| Q3 FY2020CQ2 2020 | Jun 27, 2020 | $3.55 | -0.3% |
| Q2 FY2020CQ1 2020 | Mar 28, 2020 | $4.47 | -37.0% |
| Q1 FY2020CQ4 2019 | Dec 28, 2019 | -$1.28 | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$1.04 | – |
| Q3 FY2019CQ2 2019 | Jun 29, 2019 | $3.56 | +142.2% |
| Q2 FY2019CQ1 2019 | Mar 30, 2019 | $7.09 | +173.7% |
| Q1 FY2019CQ4 2018 | Dec 29, 2018 | -$1.44 | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$2.65 | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $1.47 | -41.9% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $2.59 | -5.1% |
| Q1 FY2018CQ4 2017 | Dec 30, 2017 | -$0.37 | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$0.57 | – |
| Q3 FY2017CQ2 2017 | Jul 1, 2017 | $2.53 | – |
| Q2 FY2017CQ1 2017 | Apr 1, 2017 | $2.73 | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$1.09 | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$0.44 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?